Skip to Main Content

Paper Details

Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
J Clin Invest
9
2023
AIM2, AIM2 gene, ASXL1, Asxl1, Asxl1-mutated murine macrophages, CHIP, CVD, CVDs, Clonal hematopoiesis of indeterminate potential, DNMT3A, IL-10, IL10, IL1RAP, JAK2, TET2, blood, blood DNA, cardiovascular diseases, inflammasome-related genes, inflammatory gene modifier, murine, participants
Author NameAffiliation
Zhi YuBroad Institute of MIT and Harvard
Zhi YuCardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital
Trevor P FidlerColumbia University Irving Medical Center
Yunfeng RuanBroad Institute of MIT and Harvard
Caitlyn VlasschaertQueen's University
Caitlyn VlasschaertQueen's University
Tetsushi NakaoBroad Institute of MIT and Harvard
Tetsushi NakaoBrigham and Women's Hospital, Harvard Medical School
Tetsushi NakaoDana-Farber Cancer Institute
Tetsushi NakaoCardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital
Md Mesbah UddinBroad Institute of MIT and Harvard
Md Mesbah UddinCardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital
Taralynn MackVanderbilt University Medical Center
Abhishek NiroulaBroad Institute of MIT and Harvard
Abhishek NiroulaLund University
Abhishek NiroulaDana-Farber Cancer Institute
Jonathan B HeimlichVanderbilt University Medical Center
Seyedeh M ZekavatBroad Institute of MIT and Harvard
Seyedeh M ZekavatMassachusetts Eye and Ear Institute
Seyedeh M ZekavatCardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital
Christopher J GibsonDana-Farber Cancer Institute
Gabriel K GriffinBroad Institute of MIT and Harvard
Gabriel K GriffinBrigham and Women's Hospital
Gabriel K GriffinDana-Farber Cancer Institute
Yuxuan WangBoston University School of Public Health
Gina M PelosoBoston University School of Public Health
Nancy L Heard-CostaBoston University
Nancy L Heard-Costa
Daniel Levy
Daniel Levyand Blood Institute (NHLBI)
Daniel Levy
Daniel Levyand Blood Institute (NHLBI)
Ramachandran S VasanBoston University
Ramachandran S Vasan
Ramachandran S VasanBoston University School of Public Health
François AguetBroad Institute of MIT and Harvard
Kristin G ArdlieBroad Institute of MIT and Harvard
Kent D TaylorInstitute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Stephen S RichCenter for Public Health Genomics, University of Virginia
Jerome I RotterInstitute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Peter LibbyBrigham and Women's Hospital, Harvard Medical School
Siddhartha JaiswalDepartment of Pathology and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Benjamin L EbertBroad Institute of MIT and Harvard
Benjamin L EbertDana-Farber Cancer Institute
Alexander G BickBroad Institute of MIT and Harvard
Alexander G BickVanderbilt University Medical Center
Alan R TallColumbia University Irving Medical Center
Pradeep NatarajanBroad Institute of MIT and Harvard
Pradeep NatarajanCardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital
Pradeep NatarajanHarvard Medical School
  • 1 - 50

Datasets